This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_MELANOMA_SKIN_EXALLC for full statistics.
Malignant melanoma of skin
C3_MELANOMA_SKIN
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
4383 |
4. Check minimum number of eventsNone |
4383 |
5. Include endpointsNone |
4383 |
6. Filter based on genotype QC (FinnGen only) |
4383 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant melanoma of skin
based on the number of shared cases.
Similar with more cases:
- Malignant melanoma
- Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of skin
- Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 4383 | 2118 | 2265 |
| Unadjusted period prevalence (%) | 0.86 | 0.72 | 1.00 |
| Median age at first event (years) | 61.56 | 57.83 | 65.05 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4035
- Matched controls
- 40351
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
12004.5
323.0
939
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
624.2
323.0
396
7
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
22.0
323.0
720
395
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
692.5
323.0
320
5
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
11.5
323.0
651
663
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
22.7
323.0
1744
1310
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
470.5
323.0
863
23
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
872.7
323.0
993
15
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
4858.6
323.0
445
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
647.9
323.0
356
6
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
664.6
323.0
622
11
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
952.8
323.0
349
*
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
13.2
323.0
843
791
PJA12
NOMESCO Finland
Sentinel node biopsy
20.6
323.0
1614
1265
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
323.0
527
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
678.6
323.0
633
11
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
22.9
323.0
836
455
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
669.0
317.4
310
5
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
659.6
313.1
306
5
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.8
301.7
965
2057
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
629.2
299.3
293
5
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
1538.8
294.1
283
*
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
615.3
292.9
287
5
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.4
288.2
989
2279
C43
ICD-10 Finland
Malignant melanoma of skin
233.9
277.0
283
13
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
299.7
249.8
252
9
R23.8
ICD-10 Finland
Other and unspecified skin changes
4.0
235.9
1156
3716
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
6.3
235.0
683
1256
C43.51
ICD-10 Finland
Malignant melanoma of the trunk originating in lentigo maligna
265.8
222.5
226
9
180
Kela drug reimbursment
Interferon alfa
115.4
220.8
239
22
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
662.3
193.7
190
*
S18
ICPC
Laceration/cut
2.7
191.2
2222
12634
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
12.7
184.1
341
291
S77
ICPC
Malignant neoplasm of skin
19.3
174.0
271
150
C43.73
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip nodular
1750.6
167.8
162
*
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
16.0
162.1
271
181
8720/3-C44.3
ICD-O-3
Malignant melanoma, NOS, of skin of other and unspecified parts of face
1543.9
150.9
146
*
S82
ICPC
Naevus/mole
3.6
149.7
792
2590
L57.0
ICD-10 Finland
Actinic keratosis
3.6
149.1
769
2464
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
95.0
148.3
164
18
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
11.1
146.7
289
278
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
739.2
146.0
143
*
8743/3-C44.5
ICD-O-3
Low cumulative sun damage melanoma of skin of trunk
+∞
141.5
135
*
D22
ICD-10 Finland
Melanocytic naevi
7.1
140.0
365
561
ZZR00
NOMESCO Finland
Flap of skin
8.4
137.7
318
406
C43.63
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder nodular
1380.7
137.3
133
*
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
138.5
125.9
134
10
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
125.7
120
*
ZZA00
NOMESCO Finland
Split skin graft
6.8
125.0
335
533
130
Kela drug reimbursment
Malignant tumour
3.6
124.9
636
1992
SPAT1153
SPAT
Removal of sutures
2.3
124.9
1664
9416
C43.30
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face without histology
166.4
123.1
129
8
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
91.7
119.8
133
15
L03AB05
ATC
interferon alfa-2b; parenteral
45.8
118.3
146
33
L01XE23
ATC
[U] dabrafenib; oral
+∞
112.0
107
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
90.6
110.7
123
14
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
13.7
107.2
190
145
362
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
106.7
102
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
5.7
105.6
322
603
JN4BD
NOMESCO Finland
Extensive body CT
2.9
101.3
693
2659
C43.9
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of skin, unspecified
261.8
100.2
102
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
17.3
97.6
157
94
D03.5
ICD-10 Finland
Melanoma in situ of trunk
45.7
97.4
120
27
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
107.8
96.4
105
10
8720/3-C44.4
ICD-O-3
Malignant melanoma, NOS, of skin of scalp and neck
+∞
96.2
92
*
C43.49
ICD-10 Finland
Malignant melanoma of the scalp and neck other or unspecified histology
484.0
95.8
95
*
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
20.8
94.9
143
71
3024
Kela drug reimbursment
Dabrafenib and trametinib (adjuvant treatment)
929.2
93.2
91
*
1509
Kela drug reimbursment
Dabrafenib (adjuvant treatment)
929.2
93.2
91
*
C43.32
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face 'superficial spreading' type
165.5
92.5
97
6
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
14.5
91.6
158
113
C43.71
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip originating in lentigo maligna
452.4
89.5
89
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
5.1
85.8
289
604
C43.90
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin without histology
294.5
85.0
86
*
L01XE25
ATC
[U] trametinib; oral
+∞
82.6
79
*
C43.61
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna
405.3
80.2
80
*
C43.42
ICD-10 Finland
Malignant melanoma of the scalp and neck: 'superficial spreading' type
+∞
79.4
76
*
TQW99
NOMESCO Finland
Other minor procedure on skin
3.8
77.4
359
1021
L82
ICD-10 Finland
Seborrhoeic keratosis
2.3
76.7
802
3857
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
75.7
1230
7187
C43.00
ICD-10 Finland
Malignant melanoma of the lip without histology
198.7
75.4
78
*
C43.40
ICD-10 Finland
Malignant melanoma of the scalp and neck without histology
156.9
73.2
77
5
9734
FHL
Excision and local plastic or associated free skin grafting
14.4
70.8
122
87
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
10.8
69.5
137
131
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
4.6
68.8
250
565
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.3
65.0
253
612
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
4.7
61.8
222
495
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
60.4
1563
10570
XQ845
NOMESCO Finland
Dermatoscopy
7.0
57.5
147
217
8743/3-C44.6
ICD-O-3
Low cumulative sun damage melanoma of skin of upper limb and shoulder
+∞
57.4
55
*
QCE99
NOMESCO Finland
Other excision or repair of lesion of skin of upper limb
16.1
56.7
93
59
8743/3-C44.7
ICD-O-3
Low cumulative sun damage melanoma of skin of lower limb and hip
+∞
56.4
54
*
8720/3-C44.2
ICD-O-3
Malignant melanoma, NOS, of external ear
+∞
56.4
54
*
JN4AD
NOMESCO Finland
Body CT examination
2.6
54.6
429
1746
C43.74
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip acral
189.2
54.1
56
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.6
53.1
195
445
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.2
52.9
299
985
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
52.7
859
4907
C43.33
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face nodular
269.2
52.2
53
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
2.7
51.7
393
1567
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
51.4
1859
13674
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
9.6
51.3
107
114
L01EC02
ATC
dabrafenib; oral
504.0
50.5
50
*
8742/3-C44.9
ICD-O-3
Lentigo maligna melanoma of skin, NOS
+∞
49.0
47
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
5.4
48.8
152
290
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
13.6
47.9
84
63
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
42.7
47.6
59
14
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.9
47.1
301
1076
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.0
46.9
292
1027
C43.20
ICD-10 Finland
Malignant melanoma of the outer ear and in the external ear canal without histology
452.6
45.3
45
*
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
22.3
45.3
66
30
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
5.0
43.7
146
302
L01EE01
ATC
trametinib; oral
432.1
43.3
43
*
17281
ICD-8 Finland
Malignant melanoma of skin, Lower limb
421.8
42.2
42
*
L01AX03
ATC
temozolomide; systemic
12.0
42.2
78
66
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
4.0
42.2
174
444
C43.43
ICD-10 Finland
Malignant melanoma of the scalp and neck nodular
217.2
41.9
43
*
C43.29
ICD-10 Finland
Malignant melanoma of the outer ear and in the external ear canal other or unspecified histology
+∞
41.7
40
*
3016
Kela drug reimbursment
Binimetinib and encorafenib
+∞
41.7
40
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
4.3
41.6
160
382
1513
Kela drug reimbursment
Binimetinib and encorafenib
+∞
40.7
39
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
40.6
1274
8843
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
22.1
40.5
59
27
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
8.4
40.5
91
111
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
27.8
40.3
55
20
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.4
40.1
364
1594
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
207.0
39.9
41
*
JN4CD
NOMESCO Finland
Very extensive body CT
3.0
39.7
241
833
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
23.1
39.6
57
25
C43.4
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of scalp and neck
391.1
39.1
39
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
38.8
1538
11305
8721/3-C44.9
ICD-O-3
Nodular melanoma of skin, NOS
+∞
38.6
37
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
2.5
38.5
334
1427
ZXC50
NOMESCO Finland
Cryotherapy
3.4
38.1
195
596
XQ848
NOMESCO Finland
Dermatological photography
3.7
37.1
170
476
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
4.8
36.6
127
274
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
4.6
36.5
130
288
C43.41
ICD-10 Finland
Malignant melanoma of the scalp and neck originating in lentigo maligna
+∞
36.5
35
*
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
6.4
36.2
97
154
Z2221
NOMESCO Finland
Medical doctor
1.6
34.8
1072
7339
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.6
33.9
158
449
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
4.3
33.5
129
309
S29
ICPC
Skin symptom/complaint other
1.8
33.4
664
3993
17261
ICD-8 Finland
Malignant melanoma of skin, Trunk, except scrotum
+∞
33.4
32
*
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
2.8
32.6
226
849
I78.1
ICD-10 Finland
Naevus, non-neoplastic
3.9
31.9
134
349
R4110
NOMESCO Finland
Physiotherapy
1.6
30.8
1024
7107
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
35.8
30.5
39
11
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
10.3
30.3
60
59
8742/3-C44.3
ICD-O-3
Lentigo maligna melanoma of skin of other and unspecified parts of face
+∞
30.2
29
*
8721/3-C44.5
ICD-O-3
Nodular melanoma of skin of trunk
+∞
30.2
29
*
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
38.4
30.2
38
10
S26
ICPC
Fear of cancer of skin
5.6
29.9
89
162
1725D
ICD-9 Finland
Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,MUU TAI TARK MÄÄR]
304.5
29.8
30
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
29.8
309
1437
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
6.1
29.6
82
137
ZXA00
NOMESCO Finland
Right side
1.6
29.5
1098
7817
J01DB01
ATC
cefalexin; oral
1.5
29.2
3066
27203
WX110
NOMESCO Finland
Local anesthesy
1.5
29.1
2459
20818
S21
ICPC
Skin texture symptom/complaint
1.9
29.1
497
2830
C43.3
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of other and unspecified parts of face
57.1
29.1
34
6
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.0
29.0
178
619
9733
FHL
Excision of skin change in operating room or anesthesia
4.7
29.0
101
220
JN6AD
NOMESCO Finland
CT of torso and neck
5.0
28.9
94
190
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.4
28.9
264
1155
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.8
28.6
97
205
PJA10
NOMESCO Finland
Exploration of lymph nodes
5.0
27.7
91
186
N02BE01
ATC
paracetamol; systemic, rectal
1.6
27.6
3319
30103
DAB10
NOMESCO Finland
Partial excision of auricle
8.9
27.6
59
67
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
6.5
27.4
72
112
C43.22
ICD-10 Finland
Malignant melanoma of outer ear and outer ear canal: 'superficial spreading' type
+∞
27.1
26
*
Z51.5
ICD-10 Finland
Palliative care
2.2
27.0
288
1359
WX402
NOMESCO Finland
General anaesthesia
1.7
27.0
605
3753
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
8.3
26.5
59
72
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
6.5
26.4
69
107
H02AB02
ATC
dexamethasone; systemic
1.9
26.3
425
2370
L03AB04
ATC
interferon alfa-2a; parenteral
17.2
26.1
41
24
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
8.6
25.7
56
66
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
3.9
25.6
107
278
ZZA50
NOMESCO Finland
Full thickness skin graft
7.4
25.6
61
83
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
3.6
25.6
119
339
TQB05
NOMESCO Finland
Puncture of skin of trunk
7.2
25.5
62
87
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
5.2
25.4
80
157
DAB00
NOMESCO Finland
Excision of lesion of auricle
5.5
25.1
75
138
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
6.6
25.0
65
100
ZXA05
NOMESCO Finland
Left side
1.5
24.5
1003
7244
C43.64
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder acrally
+∞
24.0
23
*
17271
ICD-8 Finland
Malignant melanoma of skin, Upper limb
+∞
24.0
23
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
7.6
23.0
54
72
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
22.8
550
3471
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.6
22.7
105
299
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
7.1
22.5
55
78
ZXE00
NOMESCO Finland
One hour or less
1.4
22.0
1431
11290
1725A
ICD-9 Finland
Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,MELAN EX LENTIGOMAL]
+∞
21.9
21
*
WZC30
NOMESCO Finland
Teaching
1.7
21.8
512
3208
C43.89
ICD-10 Finland
Overall malignant melanoma of the skin other or unspecified histology
80.5
21.7
24
*
C43.82
ICD-10 Finland
Overall malignant melanoma of the skin: 'superficial spreading' type
80.5
21.7
24
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
5.7
21.4
62
111
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
21.2
413
2443
8742/3-C44.5
ICD-O-3
Lentigo maligna melanoma of skin of trunk
+∞
20.8
20
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.2
20.7
80
195
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
3.3
20.4
105
325
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
18.4
20.4
31
17
ZZS00
NOMESCO Finland
Rotation flap
22.4
20.3
29
13
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
9.6
20.3
41
43
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.8
19.9
134
496
1727B
ICD-9 Finland
Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,SUPERFICIAL SPREAD]
+∞
19.8
19
*
L01EC03
ATC
encorafenib; oral
+∞
19.8
19
*
L01XE15
ATC
[U] vemurafenib; oral
+∞
19.8
19
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
19.7
540
3521
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
3.1
19.7
108
351
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.5
19.6
94
276
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.5
19.6
161
668
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
4.4
19.6
71
163
C43.80
ICD-10 Finland
Overall malignant melanoma of the skin without histology
200.9
19.6
20
*
QDE00
NOMESCO Finland
Excision of loose skin or fold of skin from lower limb
46.2
19.2
23
5
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
3.4
19.0
92
273
TQW40
NOMESCO Finland
Remowal of suture of skin
1.9
18.9
270
1435
L01EE03
ATC
binimetinib; oral
+∞
18.8
18
*
1725B
ICD-9 Finland
Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,SUPERFICIAL SPREAD]
190.8
18.5
19
*
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
5.5
18.5
55
102
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
2.7
18.4
129
490
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
4.8
18.1
60
126
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
17.9
498
3256
C43.92
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin: 'superficial spreading' type
95.4
17.6
19
*
S79
ICPC
Neoplasm skin benign/unspecified
3.3
17.5
88
269
Z3226
NOMESCO Finland
Physiotherapist
1.5
17.5
661
4644
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
2.5
17.5
138
562
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.7
17.2
74
200
F16
ICPC
Eyelid symptom/complaint
2.2
17.2
180
842
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
6.4
17.0
44
69
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
4.2
16.9
64
154
TQD05
NOMESCO Finland
Puncture of skin of lower limb
21.9
16.8
24
11
C43.23
ICD-10 Finland
Malignant melanoma of the outer ear and in the outer ear canal nodular
+∞
16.7
16
*
8721/3-C44.7
ICD-O-3
Nodular melanoma of skin of lower limb and hip
+∞
16.7
16
*
1725C
ICD-9 Finland
Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,NODULARE]
+∞
16.7
16
*
C43.2
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of ear and external auricular canal
+∞
16.7
16
*
C43.09
ICD-10 Finland
Malignant melanoma of the lip other or unspecified histology
+∞
16.7
16
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
3.4
16.6
80
237
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2.5
16.6
129
519
D06BB10
ATC
imiquimod; topical
2.2
16.5
173
810
L91.0
ICD-10 Finland
Hypertrophic scar
4.5
16.4
58
131
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
2.3
16.4
158
714
B01AB05
ATC
enoxaparin; parenteral
1.4
16.2
1125
8870
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
16.1
382
2392
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
9.2
15.6
32
35
C43.91
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin originating in lentigo maligna
+∞
15.6
15
*
TQW40
SPAT
NA
2.5
15.4
125
519
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
4.4
15.2
54
123
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.4
15.0
123
512
R4120
NOMESCO Finland
Occupational therapy
1.9
15.0
228
1240
C44
ICD-10 Finland
Other malignant neoplasms of skin
7.3
14.9
35
48
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
5.4
14.9
44
82
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
4.4
14.8
53
122
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
5.5
14.8
43
79
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
7.2
14.7
35
49
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
3.4
14.7
71
212
C44.60
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including the shoulder without histology
13.2
14.7
25
19
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
2.7
14.6
103
394
8744/3-C44.9
ICD-O-3
Acral melanoma of skin, NOS
+∞
14.6
14
*
L01XE41
ATC
[U] binimetinib; oral
+∞
14.6
14
*
L01XE46
ATC
[U] encorafenib; oral
+∞
14.6
14
*
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
2.5
14.5
114
467
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
6.0
14.3
39
66
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
3.0
14.3
80
266
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.9
14.3
211
1135
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
4.3
14.3
52
122
S08
ICPC
Skin colour change
2.0
14.2
178
902
QB5S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in back
19.2
14.2
21
11
Z31.5
ICD-10 Finland
Genetic counselling
2.2
14.2
140
641
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
4.8
14.1
46
96
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
14.1
719
5347
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
4.2
14.1
53
128
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.1
13.6
73
236
A98
ICPC
Health maint/preventive medicine
1.5
13.6
3609
34350
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
21.2
13.3
19
9
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.8
13.2
227
1289
L03AA04
ATC
NA
13.8
13.2
22
16
WX002
NOMESCO Finland
Sedation and analgesia
1.4
13.0
701
5258
Z42.0
ICD-10 Finland
Follow-up care involving plastic surgery of head and neck
11.0
13.0
24
22
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
5.6
12.9
37
67
QDE20
NOMESCO Finland
Excision and repair of scar or web of skin of lower limb
10.1
12.9
25
25
TQC05
NOMESCO Finland
Puncture of skin of upper limb
13.0
12.9
22
17
8743/3-C44.4
ICD-O-3
Low cumulative sun damage melanoma of skin of scalp and neck
+∞
12.5
12
*
1726B
ICD-9 Finland
Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,SUPERFICIAL SPREAD]
+∞
12.5
12
*
8721/3-C44.6
ICD-O-3
Nodular melanoma of skin of upper limb and shoulder
+∞
12.5
12
*
C43.19
ICD-10 Finland
Malignant melanoma of eyelids including corner of eye or other unspecified histology
+∞
12.5
12
*
C43.12
ICD-10 Finland
Malignant melanoma of eyelids including corner of eye: 'superficial spreading' type
130.4
12.4
13
*
QBA10
NOMESCO Finland
Incision of skin of trunk
3.5
12.4
57
165
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
12.4
3204
29966
Z3231
NOMESCO Finland
Registered nurse
1.3
12.3
968
7723
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
11.6
12.3
22
19
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
4.7
12.2
40
85
D03.4
ICD-10 Finland
Melanoma in situ of scalp and neck
15.9
12.1
19
12
Z42.4
ICD-10 Finland
Follow-up care involving plastic surgery of lower extremity
13.4
11.9
20
15
QCE00
NOMESCO Finland
Excision of loose skin or fold of skin from upper limb
46.8
11.9
14
*
1727D
ICD-9 Finland
Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,MUU TAI TARK MÄÄR]
46.8
11.9
14
*
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
5.0
11.8
37
75
S15
ICPC
Foreign body in skin
1.8
11.8
220
1286
ELB50
NOMESCO Finland
Total parotidectomy
9.6
11.7
23
24
D18.0
ICD-10 Finland
Haemangioma, any site
2.6
11.7
83
323
E0000UV
ATC
NA
1.3
11.6
1275
10645
TQW80
NOMESCO Finland
Local dermatologic skincare
2.4
11.5
98
421
1726D
ICD-9 Finland
Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,MUU TAI TARK MÄÄR]
+∞
11.5
11
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.6
11.4
156
2617
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
6.0
11.3
30
50
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
4.7
11.3
37
79
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
10.5
11.2
21
20
WX320
NOMESCO Finland
Spinalanesthesy
1.3
11.2
791
6195
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.4
10.9
93
397
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
5.1
10.9
33
65
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
6.5
10.8
27
42
JN6CD
NOMESCO Finland
Very extensive CT of torso and neck
17.8
10.7
16
9
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
2.7
10.7
71
265
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
2.9
10.7
63
220
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
7.5
10.6
24
32
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
3.8
10.6
43
113
C43.93
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin nodular
60.1
10.6
12
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
3.1
10.6
56
182
C43.21
ICD-10 Finland
Malignant melanoma of the outer ear and in the external ear canal originating in lentigo maligna
110.3
10.4
11
*
1727A
ICD-9 Finland
Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,MELAN EX LENTIGOMAL]
+∞
10.4
10
*
C43.54
ICD-10 Finland
Malignant melanoma of the torso acral
+∞
10.4
10
*
8743/3-C44.3
ICD-O-3
Low cumulative sun damage melanoma of skin of other and unspecified parts of face
+∞
10.4
10
*
1727C
ICD-9 Finland
Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,NODULARE]
+∞
10.4
10
*
1XC18
NOMESCO Finland
NA
+∞
10.4
10
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
4.7
10.4
34
73
WF002
NOMESCO Finland
Radical radiotherapy
1.7
10.4
193
1129
A54
ICPC
General and Unspecified, Repair/fix-suture/cast/prosth device
2.8
10.3
66
242
HA1AA
NOMESCO Finland
X-ray mammography
1.7
10.3
221
1347
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
4.6
10.3
34
74
-54
ICPC
Repair/fix-suture/cast/prosth device
2.3
9.9
92
410
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
4.4
9.8
34
78
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
3.8
9.8
40
107
S97
ICPC
Chronic ulcer skin
1.7
9.7
193
1152
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
4.0
9.6
37
94
R23
ICD-10 Finland
Other skin changes
3.2
9.5
47
146
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
5.2
9.5
28
54
D03.2
ICD-10 Finland
Melanoma in situ of ear and external auricular canal
100.2
9.4
10
*
8720/3-C44.1
ICD-O-3
Malignant melanoma, NOS, of eyelid
+∞
9.4
9
*
8720/3-C44.8
ICD-O-3
Malignant melanoma, NOS, of overlapping lesion of skin
+∞
9.4
9
*
8742/3-C44.6
ICD-O-3
Lentigo maligna melanoma of skin of upper limb and shoulder
+∞
9.4
9
*
C43.02
ICD-10 Finland
Malignant melanoma of lip: 'superficial spreading' type
+∞
9.4
9
*
PXA20
NOMESCO Finland
Extracorporal circulation of lower extremity using heart-lung assist device
+∞
9.4
9
*
8744/3-C44.7
ICD-O-3
Acral melanoma of skin of lower limb and hip
+∞
9.4
9
*
D06BX02
ATC
ingenol mebutate; topical
2.6
9.4
64
245
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.5
9.4
68
270
ZZS10
NOMESCO Finland
Transposition flap
21.7
9.3
13
6
QWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of skin
5.3
9.3
27
51
5702
FHL
Local lymph node removal (eg armpit, groin)
5.8
9.3
25
43
Z42.2
ICD-10 Finland
Follow-up care involving plastic surgery of other parts of trunk
10.7
9.3
17
16
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
3.1
9.2
48
155
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
2.4
9.2
76
321
D48
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other and unspecified sites
7.7
9.1
20
26
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
6.2
9.1
23
37
C44.59
ICD-10 Finland
Malignant tumor of the skin on the trunk other or unspecified histology
8.3
9.0
19
23
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.3
9.0
78
338
S04
ICPC
Lump/swelling localized
1.5
9.0
274
1827
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
3.0
9.0
49
164
SPAT1211
SPAT
Application of soft bandage
1.5
8.9
289
1955
ELB40
NOMESCO Finland
Partial parotidectomy
3.0
8.8
49
166
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.2
8.7
86
397
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.5
8.6
277
1872
WX702
NOMESCO Finland
Supraglottic ventilation device
1.7
8.6
166
981
WF004
NOMESCO Finland
Palliative radiotherapy
2.2
8.4
79
358
C43.8
ICD-10 Finland
Malignant neoplasm: Overlapping malignant melanoma of skin
+∞
8.3
8
*
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
3.3
8.3
39
118
A04AA02
ATC
granisetron; systemic, transdermal
1.6
8.3
196
1228
C44.70
ICD-10 Finland
Malignant tumor of the skin of the lower extremity including the hip without histology
9.4
8.3
16
17
9801
FHL
Free skin graft
6.0
8.1
21
35
TQX00
NOMESCO Finland
Needle biopsy of skin
17.2
8.1
12
7
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.2
7.9
79
369
A04AA01
ATC
ondansetron; systemic, rectal
1.6
7.9
211
1365
-59
ICPC
Other therap proced/minor surg NEC
2.1
7.9
90
443
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
3.5
7.7
34
98
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
1.9
7.7
100
522
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
2.6
7.7
53
205
TNG34
NOMESCO Finland
Major custom moulded orthopaedic cast, knee or lower leg
2.8
7.7
45
159
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
3.8
7.6
30
79
WB501
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of primary tumour
18.4
7.6
11
6
C43.11
ICD-10 Finland
Malignant melanoma of the eyelids including corner of the eye originating in lentigo maligna
25.0
7.6
10
*
QBE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of trunk
11.8
7.6
13
11
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
4.9
7.6
23
47
Q82.58
ICD-10 Finland
Congenital non-neoplastic naevus
3.6
7.5
32
90
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
5.1
7.5
22
43
N02AA05
ATC
oxycodone; systemic
1.3
7.5
502
3883
ZXC15
NOMESCO Finland
Use of photodynamic technique
2.4
7.5
59
246
ZQZ00
NOMESCO Finland
Treatment of several skin areas
3.3
7.4
35
107
C43.81
ICD-10 Finland
Overall malignant melanoma of the skin originating in lentigo maligna
80.2
7.4
8
*
D23
ICD-10 Finland
Other benign neoplasms of skin
2.4
7.4
58
240
QB3S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in abdomen
13.4
7.4
12
9
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
4.7
7.3
23
49
1726A
ICD-9 Finland
Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,MELAN EX LENTIGOMAL]
+∞
7.3
7
*
8721/3-C44.3
ICD-O-3
Nodular melanoma of skin of other and unspecified parts of face
+∞
7.3
7
*
R03BB04
ATC
tiotropium bromide; inhalant
0.7
7.2
171
2538
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
3.7
7.2
29
78
D03.8
ICD-10 Finland
Melanoma in situ of other sites
30.0
7.1
9
*
S59
ICPC
Skin, Other therap proced/minor surg NEC
2.6
7.1
47
180
Z00.0
ICD-10 Finland
General medical examination
1.3
7.1
572
4545
Z08
ICD-10 Finland
Follow-up examination after treatment for malignant neoplasms
12.0
7.1
12
10
ZXB10
NOMESCO Finland
Medial
3.6
7.0
29
80
R23.4
ICD-10 Finland
Changes in skin texture
3.0
7.0
38
129
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
3.4
7.0
32
96
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.0
7.0
86
441
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
4.0
7.0
26
66
QDA10
NOMESCO Finland
Incision of skin of lower limb
3.1
6.9
35
113
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
3.0
6.9
36
119
QX4YT
NOMESCO Finland
Puncture of superficial collection under ultrasound guidance
6.7
6.8
16
24
C43.10
ICD-10 Finland
Malignant melanoma of eyelids including corner of eye without histology
40.1
6.8
8
*
8720/3-C80.9
ICD-O-3
Malignant melanoma, NOS, of unknown primary site
40.1
6.8
8
*
PJ003
NOMESCO Finland
Adjuvant radiotherapy of neck, clavicle and axilla
40.1
6.8
8
*
WC325
NOMESCO Finland
Demanding therapy of local tumor recidive with biomodifiers
40.1
6.8
8
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
6.7
448
3464
XX1XT
NOMESCO Finland
Other puncture with other radiological guidance
5.2
6.6
19
37
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
6.5
709
5857
D22.2
ICD-10 Finland
Melanocytic naevi of ear and external auricular canal
6.2
6.5
16
26
PJ5SN
NOMESCO Finland
Sentinell SPECT with low dose CT
69.9
6.4
7
*
QA3S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in ear
69.9
6.4
7
*
ZXC20
NOMESCO Finland
Use of chemical agents
2.0
6.4
77
391
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1.6
6.4
141
871
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
1.9
6.4
85
449
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
1.7
6.3
111
642
ZZR30
NOMESCO Finland
Flap of muscle
4.2
6.3
22
53
8721/3-C44.4
ICD-O-3
Nodular melanoma of skin of scalp and neck
+∞
6.2
6
*
17241
ICD-8 Finland
Malignant melanoma of skin, Scalp and neck
+∞
6.2
6
*
1726C
ICD-9 Finland
Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,NODULARE]
+∞
6.2
6
*
8743/3-C44.2
ICD-O-3
Low cumulative sun damage melanoma of external ear
+∞
6.2
6
*
C43.1
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of eyelid, including canthus
+∞
6.2
6
*
C43.83
ICD-10 Finland
Overall malignant melanoma of the skin nodular
+∞
6.2
6
*
C43.94
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin acrally
+∞
6.2
6
*
D03.30
ICD-10 Finland
Melanoma in situ on the lip
26.7
6.2
8
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
2.7
6.2
38
140
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
2.1
6.2
62
293
QCE20
NOMESCO Finland
Excision and repair of scar or web of skin of upper limb
7.0
6.2
14
20
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
3.4
6.2
27
79
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
6.2
1355
12010
QBE99
SPAT
NA
3.5
6.2
26
74
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
6.2
86
464
QBA00
NOMESCO Finland
Puncture of skin of trunk
4.5
6.1
20
45
A02BC02
ATC
pantoprazole; systemic
1.2
6.1
2284
21188
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
3.6
6.1
25
70
K03.64
ICD-10 Finland
Dental calculus supragingival
1.2
6.0
727
6067
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
4.4
6.0
20
46
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
1534
4815
4.36
307.65
1.8
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
3107
14643
4.85
307.65
3.8
2.1
—
—
—
0
0
(4035726)
1172
3307
4.47
307.65
1.5
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1214
4578
3.28
244.93
8.3
4.1
u/l
240.9
243.9
0.16
1182
4314
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
112
12
95.75
215.00
1.0
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
244
405
6.32
141.20
1.8
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
513
1610
3.48
133.65
1.3
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
253
657
4.03
86.22
1.4
1.3
u/l
13.9
11.2
1.81
209
531
(3036481) Cortisol [Moles/volume] in Serum or Plasma
661
3206
2.25
71.87
7.2
2.1
nmol/l
373.1
369.7
0.18
634
2927
(40768795) Lymph node Pathology biopsy report
157
342
4.72
67.06
1.1
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1661
11828
1.65
52.28
2.5
2.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2482
19600
1.61
50.61
9.6
6.2
umol/l
11.6
11.8
0.45
2388
18599
(3013650) Neutrophils [#/volume] in Blood by Automated count
2586
20917
1.58
45.20
12.0
8.8
e9/l
4.1
4.2
1.94
2289
18194
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2186
17208
1.54
41.68
4.0
4.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3289
28469
1.62
40.29
11.0
7.7
u/l
80.0
79.5
0.20
3117
26775
(3033658) Prothrombin time (PT) actual/Normal
1328
9451
1.58
39.15
4.1
4.0
%
88.9
87.2
1.62
1307
9219
(42870588) Differential panel, method unspecified - Blood
1673
12557
1.54
38.82
7.2
5.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
229
902
2.62
38.80
1.3
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1257
9089
1.54
33.47
2.5
2.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
189
735
2.64
32.84
1.8
1.6
mu/l
284.1
301.1
0.41
179
672
(3006315) Basophils [#/volume] in Blood
2212
18052
1.45
31.68
7.2
5.7
e9/l
0.0
0.0
0.44
1900
15495
(3001604) Monocytes [#/volume] in Blood
2198
17956
1.45
31.07
7.2
5.6
e9/l
0.6
0.6
2.94
1889
15395
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3680
33373
1.64
30.81
18.5
15.1
ml/min/173m2
76.7
76.6
0.05
3233
27747
(3019198) Lymphocytes [#/volume] in Blood
2239
18408
1.44
30.25
7.2
5.7
e9/l
1.9
1.9
0.12
1958
16080
(3023323) Follitropin [Units/volume] in Serum or Plasma
224
990
2.33
29.58
1.3
1.3
iu/l
26.0
32.8
2.35
180
851
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
109
331
3.35
29.44
1.6
1.4
u/l
31.2
33.3
0.25
102
272
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
188
770
2.51
29.37
1.5
1.8
iu/l
3.8
4.4
0.20
45
260
(3013115) Eosinophils [#/volume] in Blood
2260
18679
1.43
29.26
7.3
5.9
e9/l
0.2
0.2
0.25
1976
16251
(3015377) Calcium [Moles/volume] in Serum or Plasma
1647
12857
1.45
29.02
5.9
3.4
mmol/l
2.4
2.4
1.70
1462
11094
(3022096) Basophils/100 leukocytes in Blood
2020
16418
1.43
28.35
7.4
6.0
%
0.7
0.7
1.70
1890
15232
(40758558) Short blood count panel - Blood
1231
9154
1.48
27.60
9.6
6.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
2072
16979
1.42
27.44
7.6
6.2
%
8.7
8.8
0.49
1949
15803
(3006504) Eosinophils/100 leukocytes in Blood
2059
16890
1.41
26.91
7.4
5.9
%
2.9
2.9
0.63
1930
15664
(3002030) Lymphocytes/100 leukocytes in Blood
2105
17341
1.41
26.81
7.5
6.1
%
27.1
26.9
0.28
1971
16037
(3019550) Sodium [Moles/volume] in Serum or Plasma
3960
36967
1.74
25.36
21.1
18.6
mmol/l
139.7
139.6
0.92
3878
36049
(3023103) Potassium [Moles/volume] in Serum or Plasma
3966
37054
1.74
25.12
21.3
18.8
mmol/l
4.0
4.0
4.70
3876
36081
(3018010) Neutrophils/100 leukocytes in Blood
2065
17090
1.39
24.89
7.2
5.8
%
57.9
57.9
0.02
1936
15887
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
44
77
5.76
24.11
1.1
1.8
ug/l
1.9
2.1
0.22
17
43
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2091
17445
1.38
23.47
6.4
6.1
mmol/l
1.2
1.2
2.00
1909
15750
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
978
7164
1.47
22.97
4.9
3.1
mmol/l
2.5
2.5
0.09
884
6277
(40761511) CBC panel - Blood by Automated count
3891
36403
1.61
21.62
16.2
15.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1896
15776
1.36
20.68
11.7
10.0
e9/l
0.0
0.0
0.55
1568
12895
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
37
65
5.73
20.21
12.2
3.3
u/l
64.6
39.8
0.61
14
19
(3013826) Glucose [Moles/volume] in Serum or Plasma
2545
22240
1.34
19.58
5.9
4.8
mmol/l
6.7
6.8
1.69
2433
20913
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2240
19250
1.33
19.09
6.9
6.9
mmol/l
1.2
1.2
2.29
1863
16202
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3785
35374
1.51
19.09
18.2
15.9
mg/l
25.3
25.4
0.11
3125
28579
(3007461) Platelets [#/volume] in Blood
4071
38736
1.72
18.59
27.3
23.4
e9/l
245.5
245.3
0.06
3990
37688
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3967
37507
1.61
18.49
14.1
11.0
u/l
25.6
25.9
0.25
3834
36039
(3024731) MCV [Entitic volume]
4071
38748
1.71
18.41
27.2
23.3
fl
91.2
91.5
4.32
4020
38127
(3018418) pH of Serum or Plasma
1414
11396
1.36
18.37
4.9
4.1
ph
7.4
7.4
0.70
278
2190
(3026361) Erythrocytes [#/volume] in Blood
4071
38751
1.71
18.36
27.3
23.4
e12/l
4.5
4.4
2.41
3986
37576
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2963
26611
1.35
18.30
5.1
3.9
pmol/l
15.0
14.9
1.30
2675
23949
(3000963) Hemoglobin [Mass/volume] in Blood
4071
38761
1.71
18.21
27.5
23.5
g/l
134.5
134.3
0.20
4024
38149
(3035941) MCH [Entitic mass]
4069
38748
1.70
18.04
27.2
23.3
pg
30.3
30.4
3.80
4018
38126
(3007853) Bacteria identified in Skin by Aerobe culture
622
4351
1.50
17.96
1.8
1.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
4069
38758
1.70
17.89
27.4
23.4
e9/l
6.8
6.8
0.13
3980
37580
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3490
32250
1.40
17.47
6.0
4.7
mu/l
1.9
2.1
1.01
3162
29190
(3012095) Magnesium [Moles/volume] in Serum or Plasma
842
6300
1.42
16.99
3.6
3.2
mmol/l
0.8
0.8
1.00
791
5854
(3024561) Albumin [Mass/volume] in Serum or Plasma
1945
16584
1.31
16.61
6.2
4.9
g/l
35.2
35.0
1.11
1828
15363
(3042936) Bacteria identified in Isolate by Culture
724
5415
1.40
14.42
2.0
2.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
307
1933
1.63
14.01
1.3
1.2
iu/ml
137.1
142.4
0.07
74
706
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1414
11791
1.29
13.42
5.1
2.5
u/l
57.8
58.2
0.12
1299
10880
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
234
1401
1.71
12.96
2.7
2.2
ug/l
238.3
625.7
1.84
226
1317
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
475
3395
1.45
12.07
3.1
2.4
u/l
34.2
39.5
0.86
421
2892
(3032080) INR in Blood by Coagulation assay
1859
16190
1.26
11.98
9.4
10.4
inr
1.3
1.3
1.34
496
4523
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
304
1984
1.57
11.95
4.0
3.3
pmol/l
4.3
4.4
0.50
280
1733
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
511
3722
1.42
11.70
1.6
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
2666
24291
1.25
11.15
4.5
4.8
e6/l
317.6
1720.5
2.63
33
370
(3003694) ABO and Rh group [Type] in Blood
1121
9265
1.28
10.96
1.4
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
378
2638
1.47
10.86
2.0
2.1
nmol/l
11.0
12.3
2.12
328
2279
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1380
11747
1.26
10.46
2.5
2.2
u/l
185.3
212.8
0.86
1309
10965
(3017143) Hepatitis C virus Ab [Presence] in Serum
447
3248
1.42
10.34
1.6
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
29
76
3.83
9.93
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
304
2069
1.50
9.89
1.4
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
3078
28658
1.25
9.88
22.5
19.3
%
13.8
13.8
0.17
3034
28013
(3009542) Hematocrit [Volume Fraction] of Blood
3321
31200
1.27
9.81
19.6
17.1
%
39.6
39.2
1.89
2296
20810
(3044889) 12 lead EKG panel
2799
25806
1.23
9.77
4.5
4.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1221
10317
1.25
9.73
3.6
3.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
933
7662
1.28
9.40
5.0
3.9
ng/l
144.0
531.3
2.59
771
6334
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
530
4051
1.35
8.99
3.7
3.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
62
267
2.34
8.92
1.1
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1250
10683
1.24
8.83
3.6
3.3
e6/l
0.4
0.5
1.45
947
8119
(3018095) Leukocytes [#/volume] in Urine
1528
13354
1.22
8.67
4.1
3.8
e6/l
102.5
108.3
0.09
1102
9676
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
755
6101
1.29
8.58
3.2
3.1
e6/l
1.7
2.1
1.01
405
3373
(3014111) Lactate [Moles/volume] in Serum or Plasma
461
3476
1.36
8.53
5.8
6.6
mmol/l
1.4
1.4
0.17
443
3353
(3037467) Urinalysis macro (dipstick) panel - Urine
2714
25107
1.21
8.47
4.4
4.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3631
34681
1.27
8.15
5.3
4.9
mmol/l
6.0
6.0
2.23
3255
31291
(3023368) Bacteria identified in Blood by Culture
1277
11049
1.22
7.83
4.3
4.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
428
3256
1.35
7.47
8.1
8.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
63
297
2.14
7.37
5.3
5.0
u/ml
97.2
50.1
0.33
22
81
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
333
2454
1.39
7.11
1.6
1.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1332
11667
1.20
7.05
3.7
3.4
e6/l
134.0
93.7
0.26
1027
9050
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1373
12064
1.20
7.02
3.0
3.1
ng/l
1387.2
1603.7
1.31
1177
10456
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
534
4242
1.29
6.86
3.7
4.0
ug/l
9.5
21.5
2.42
413
3485
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
786
6546
1.24
6.81
3.1
2.9
e6/l
1.9
1.2
0.57
435
3785
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
48
210
2.30
6.75
6.0
6.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
50
226
2.23
6.53
2.6
2.1
e6/l
514.8
666.9
0.67
13
99
(3013512) EKG study
1286
11349
1.19
6.09
4.6
4.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
49
228
2.16
5.99
1.4
1.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
610
5022
1.25
5.82
7.7
6.7
mmol/l
104.3
104.4
0.11
604
4896
(3020779) Urea [Moles/volume] in Serum or Plasma
459
3661
1.28
5.71
7.3
7.2
mmol/l
10.5
10.6
0.10
443
3466
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
250
1831
1.39
5.59
5.3
3.9
mmol/l
24.2
24.2
0.02
230
1636
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
115
720
1.61
5.56
3.8
3.7
%
57.0
58.0
0.35
115
720
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
514
4195
1.26
5.29
2.8
2.7
umol/l
9.9
9.0
0.30
454
3675
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
146
983
1.50
5.15
1.2
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1290
11519
1.17
5.14
3.8
3.2
u/l
31.7
36.9
2.04
1218
10917
(3003458) Phosphate [Moles/volume] in Serum or Plasma
615
5139
1.23
5.10
6.7
5.9
mmol/l
1.0
1.0
0.16
578
4763
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
282
2139
1.34
5.08
7.5
8.9
mmol/l
24.4
24.3
0.35
268
1994
(3007930) Methemoglobin/Hemoglobin.total in Blood
113
1723
0.65
5.01
3.7
5.3
%
0.8
0.9
1.73
105
1610
(3052851) Hemolysis interference index of Serum or Plasma
165
1146
1.46
4.99
3.2
3.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
116
749
1.56
4.96
1.3
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
115
1739
0.65
4.91
3.6
5.2
%
1.5
1.6
0.64
106
1624
(3014765) Yersinia sp identified in Stool by Organism specific culture
145
989
1.48
4.82
1.2
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
521
4312
1.24
4.73
1.7
1.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
141
962
1.48
4.69
2.5
2.3
%
193.9
197.0
0.15
135
916
(3013707) Erythrocyte sedimentation rate by Westergren method
2825
26805
1.15
4.69
4.0
4.2
mm/h
12.5
13.3
2.36
2585
24647
(42529406) Shigella sp [Presence] in Stool by Culture
145
997
1.47
4.65
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
200
1459
1.39
4.63
3.0
3.4
u/ml
2045.9
3604.7
0.29
179
1237
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1623
14863
1.15
4.45
4.3
3.9
ng/l
46.9
85.4
0.68
1224
10935
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
86
535
1.62
4.35
1.1
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
106
693
1.54
4.34
4.7
5.3
iu/ml
405.7
2701.3
0.54
19
103
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3669
35587
1.19
4.32
5.2
5.2
mmol/l
2.7
2.7
0.01
3299
32450
(21494815) CD4 cells/100 lymphocytes in Specimen
50
269
1.87
4.21
1.7
2.1
%
38.4
43.0
—
5
31
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
148
1043
1.43
4.21
2.0
2.1
%
93.2
89.7
0.92
143
985
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3562
34485
1.18
4.18
4.7
4.6
mmol/l
1.5
1.4
0.37
3200
31401
(3000494) Fungus identified in Specimen by Culture
513
4307
1.22
4.06
1.4
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
114
775
1.48
3.92
1.2
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
557
4740
1.20
3.83
4.9
4.7
%
33.0
32.9
0.07
362
3149
(3026782) Osmolality of Urine
868
7670
1.16
3.82
3.1
2.8
mosm/kgh2o
550.6
550.2
0.02
737
6524
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3449
33369
1.16
3.81
4.2
4.1
mmol/l
1.3
1.3
0.53
3062
30126
(3018572) Chloride [Moles/volume] in Blood
57
950
0.59
3.79
5.1
7.2
mmol/l
105.2
105.0
0.12
50
846
(3039000) Anion gap in Blood
57
949
0.60
3.78
5.1
7.2
mmol/l
11.1
11.3
0.12
50
845
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3583
34776
1.17
3.74
4.7
4.6
mmol/l
4.6
4.6
0.30
3244
31897
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1606
14829
1.13
3.71
2.1
2.2
nmol/l
79.3
78.7
0.39
1405
13137
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
85
552
1.55
3.65
1.5
1.4
u/ml
121.7
120.1
0.05
15
110
(3036489) Thrombin time
177
1323
1.35
3.60
2.0
1.9
s
21.3
21.5
0.42
163
1173
(40760892) CBC W Ordered Manual Differential panel - Blood
854
7570
1.16
3.59
5.1
4.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
923
8232
1.15
3.57
2.9
2.7
e6/l
4.9
5.0
0.09
807
7208
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
94
628
1.51
3.56
1.5
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
940
8405
1.15
3.51
3.4
3.2
ug/l
0.8
0.8
0.12
707
5903
(3019150) Specific gravity of Urine by Refractometry
683
7776
0.86
3.43
4.0
4.3
kg/l
1.0
1.0
0.26
91
1190
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
154
1136
1.37
3.43
1.6
1.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
88
1292
0.67
3.35
4.2
6.4
mmol/l
1.4
1.3
0.40
76
1136
(3023419) Bacteria identified in Sputum by Culture
26
519
0.50
3.26
2.2
2.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
113
799
1.43
3.24
1.3
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
19
78
2.44
3.21
1.1
1.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
60
371
1.63
3.20
1.3
1.2
u/l
49.6
59.6
0.60
38
249
(3008757) Leukocyte morphology finding [Identifier] in Blood
68
436
1.57
3.14
4.7
4.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
555
4811
1.18
3.11
8.3
7.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3420
33199
1.14
3.10
6.3
6.2
mmol/mol
40.1
40.4
1.11
3084
30447
(3008152) Bicarbonate [Moles/volume] in Arterial blood
209
2640
0.78
3.05
7.6
6.7
mmol/l
24.9
24.5
0.92
195
2460
(3017569) Oxygen content in Arterial blood
7
214
0.33
3.04
1.3
2.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
42
241
1.75
2.97
1.1
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
700
6206
1.15
2.92
2.0
2.0
s
30.4
29.9
0.90
673
6017
(3022217) INR in Platelet poor plasma by Coagulation assay
634
5581
1.16
2.92
26.1
27.4
inr
1.4
1.4
0.18
67
786
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
77
518
1.50
2.89
2.0
2.2
mg/l
25.0
24.6
0.02
21
117
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1702
15942
1.11
2.87
2.1
2.1
pmol/l
94.5
94.0
0.14
876
8327
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
754
8415
0.87
2.85
1.7
1.7
pmol/l
17413386.6
33884243.3
0.42
603
6903
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
186
1453
1.29
2.85
2.4
2.9
u/ml
0.4
0.3
0.11
114
832
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
137
1025
1.35
2.84
1.2
1.5
g/l
1.2
1.2
0.82
130
969
(3023410) Appearance of Cerebral spinal fluid
52
321
1.63
2.83
1.2
1.5
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
72
480
1.51
2.82
1.6
1.4
mu/l
35.7
58.8
1.27
64
426
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
612
5388
1.16
2.82
2.8
2.6
%
21.9
22.5
0.46
537
4560
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
93
656
1.43
2.75
3.9
3.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
202
1604
1.27
2.73
2.2
3.6
u/ml
39.2
67.1
1.26
197
1542
(3024869) Neuronal Ab [Presence] in Serum
17
73
2.33
2.64
1.2
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
733
6573
1.14
2.59
1.8
1.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
226
0.40
2.54
1.1
2.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
358
3047
1.19
2.52
4.4
4.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
644
5742
1.14
2.49
2.7
2.6
g/l
2.3
2.3
0.55
598
5316
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
9
26
3.47
2.48
1.0
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
16
4.38
2.47
1.1
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
237
1943
1.23
2.46
1.7
1.7
g/l
1.5
1.6
1.02
208
1666
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
26
137
1.90
2.45
2.6
2.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
230
2794
0.81
2.43
4.4
4.7
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
38
227
1.68
2.39
1.2
1.1
mg/l
46.7
43.9
0.12
30
189
(40768800) Prostate Pathology biopsy report
127
968
1.32
2.38
1.1
1.2
—
—
—
0
0
(3019225) pH of Specimen
460
4019
1.16
2.37
4.4
4.6
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
8
22
3.64
2.36
1.1
1.0
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
24
126
1.91
2.30
1.1
1.3
ug/l
17.5
412.5
1.15
11
65
(3026493) Urate [Moles/volume] in Serum or Plasma
1091
10086
1.11
2.28
3.1
2.8
umol/l
5462.7
5604.7
0.04
951
8604
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
54
357
1.52
2.27
1.3
1.3
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
32
532
0.60
2.25
2.4
2.3
mmol/l
4.1
4.1
0.24
32
524
(3035285) Chloride [Moles/volume] in Venous blood
32
532
0.60
2.25
2.4
2.3
mmol/l
105.6
105.4
0.10
32
524
(3033705) Calcium.ionized [Moles/volume] in Venous blood
31
519
0.59
2.24
2.5
2.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
37
225
1.65
2.20
1.9
1.6
u/l
5.3
6.6
0.37
23
107
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
36
220
1.64
2.11
1.1
1.0
mg/l
341.8
300.7
0.31
28
188
(3049717) Cytology report of Urine Cyto stain
207
1704
1.23
2.11
2.8
2.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
181
1471
1.24
2.08
1.2
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
92
684
1.35
2.08
3.2
3.5
%
1.1
1.6
1.14
71
524
(3014271) Vancomycin [Susceptibility]
38
237
1.61
2.07
2.9
3.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
38
237
1.61
2.07
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
38
237
1.61
2.07
1.1
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
462
4083
1.15
2.06
1.3
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
481
4263
1.14
2.05
1.4
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
58
829
0.70
2.04
1.1
1.1
u/ml
5.4
5.8
—
7
79
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
855
7848
1.11
2.04
1.7
1.7
mg/l
1.6
1.3
0.53
680
6070
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
38
238
1.60
2.04
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
207
1713
1.22
2.02
2.1
1.9
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
38
240
1.59
1.98
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
38
240
1.59
1.98
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
38
240
1.59
1.98
1.1
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
114
882
1.30
1.98
1.5
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
34
210
1.62
1.94
1.1
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1550
14668
1.09
1.93
5.7
5.3
ug/l
3.9
3.9
0.01
1369
13092
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
180
1476
1.23
1.93
2.0
1.8
u/l
41.3
38.4
1.05
160
1271
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
44
290
1.52
1.92
1.2
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
67
482
1.40
1.88
1.7
2.3
u/ml
129.6
672.9
0.49
67
466
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
74
542
1.37
1.87
1.2
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
15
72
2.09
1.86
1.2
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
45
301
1.50
1.84
1.1
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2013
19282
1.08
1.84
2.5
2.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
248
2109
1.19
1.83
1.3
1.3
au/ml
44.3
50.2
0.12
11
102
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
10
40
2.50
1.83
1.2
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
10
40
2.50
1.83
1.2
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
10
40
2.50
1.83
1.2
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
150
1215
1.24
1.82
1.9
2.3
g/l
0.0
0.0
1.62
132
1113
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
79
588
1.35
1.81
1.3
1.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
98
753
1.31
1.81
1.3
1.4
e6/l
486.8
1220.6
0.86
79
615
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
98
754
1.31
1.80
1.3
1.4
e6/l
9.3
23.9
1.01
75
581
(3041806) Other cells [#/volume] in Blood by Manual count
7
23
3.05
1.80
1.9
1.7
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
141
1136
1.25
1.79
2.0
2.3
g/l
0.0
0.0
0.39
123
1039
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
139
1119
1.25
1.78
2.0
2.4
g/l
0.0
0.0
0.00
123
1038
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
48
328
1.47
1.78
1.2
1.3
u/l
9.6
13.3
1.55
43
297
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
13
60
2.17
1.77
1.2
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
72
531
1.36
1.76
1.1
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
34
216
1.58
1.76
1.2
1.1
nmol/l
3.5
7.5
—
9
50
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
190
1584
1.21
1.76
1.8
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
57
404
1.42
1.76
1.2
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
27
162
1.67
1.74
1.0
1.5
ug/l
2.6
5.0
0.69
19
127
(3010370) Gastrin [Moles/volume] in Serum or Plasma
12
54
2.23
1.73
2.7
1.6
pmol/l
41.1
36.4
0.08
12
44
(4027681)
28
170
1.65
1.73
1.4
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
409
3638
1.14
1.69
1.9
2.2
g/l
0.2
0.2
1.86
382
3377
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
58
419
1.39
1.63
1.9
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
149
0.40
1.62
1.2
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
43
2.33
1.60
5.5
5.3
—
—
—
0
0
(4010399)
223
2599
0.85
1.59
1.4
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
44
304
1.45
1.58
2.4
2.4
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
6
20
3.00
1.58
1.3
1.2
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
7
26
2.69
1.58
1.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
27
167
1.62
1.58
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
65
482
1.35
1.57
1.7
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
11
50
2.20
1.56
1.2
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
337
2977
1.14
1.56
4.4
3.8
ng/l
107.6
95.6
0.97
296
2526
(1761482) Bacteria [#/volume] in Urine by Culture
81
1045
0.77
1.54
3.8
4.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
15
3.34
1.52
1.0
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
671
6179
1.10
1.52
2.7
2.6
umol/l
12.3
12.7
0.65
622
5723
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
37
249
1.49
1.52
1.3
1.3
mmol/l
10.8
12.1
0.70
16
77
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1283
13528
0.93
1.51
3.8
4.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
44
0.00
1.51
0.0
2.7
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
11
51
2.16
1.50
12.1
13.2
mmol/l
3.9
5.5
3.15
11
51
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
122
991
1.24
1.49
1.2
1.5
g/l
0.2
0.2
0.07
115
936
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
166
1393
1.20
1.48
2.0
2.5
g/l
0.9
1.1
0.28
137
1195
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
365
3257
1.13
1.47
4.6
4.0
mmol/l
1.2
1.2
0.74
325
2861
(3028308) Erythrocytes [#/volume] in Pleural fluid
65
488
1.34
1.46
1.5
1.4
e6/l
88162.3
75450.7
0.16
39
294
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
48
343
1.40
1.46
1.7
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
28
179
1.57
1.45
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
32
474
0.67
1.45
1.3
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
267
2337
1.15
1.43
2.5
2.4
au/ml
30.8
25.1
0.25
12
101
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
498
4535
1.11
1.42
1.7
1.8
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
108
873
1.24
1.40
1.4
1.3
mg/l
537.1
551.1
0.14
103
822
(3017354) Segmented neutrophils/100 leukocytes in Blood
57
423
1.35
1.40
2.8
3.7
%
56.3
57.9
0.17
38
266
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
60
449
1.34
1.39
1.4
1.4
pmol/l
313.6
274.7
0.35
46
348
(3011397) Hemoglobin [Presence] in Urine by Test strip
904
8472
1.08
1.39
3.3
3.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
88
696
1.27
1.38
1.4
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
97
777
1.25
1.37
1.4
1.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
16
89
1.80
1.37
5.2
5.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
27
174
1.56
1.37
1.0
1.1
iu/ml
8.4
12.4
—
6
48
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
178
1517
1.18
1.36
2.1
2.4
g/l
3.0
3.1
0.53
131
1189
(3035880) pH of Pleural fluid
36
248
1.46
1.35
1.3
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
60
452
1.33
1.34
1.2
1.3
nmol/l
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
76
592
1.29
1.34
1.2
1.2
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
37
0.00
1.34
0.0
2.4
—
1.1
—
0
24
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
56
418
1.34
1.33
1.1
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
48
350
1.38
1.32
2.1
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
48
350
1.38
1.32
2.1
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
48
350
1.38
1.32
2.1
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
151
1272
1.19
1.32
1.9
2.3
g/l
38.1
37.5
0.65
125
1086
(3023199) Leukocytes [#/volume] in Pleural fluid
70
541
1.30
1.32
1.5
1.5
e6/l
1739.3
1738.0
0.00
54
396
(3003327) Ova and parasites identified in Stool by Light microscopy
118
971
1.22
1.31
1.4
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
42
300
1.40
1.31
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
42
300
1.40
1.31
1.3
1.4
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
6
24
2.50
1.30
2.3
2.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
42
301
1.40
1.29
1.3
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
46
335
1.38
1.28
1.1
1.1
—
41.3
—
0
6
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
39
276
1.42
1.28
1.2
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
327
2927
1.13
1.28
3.6
3.9
%
0.6
0.6
0.15
80
688
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2307
22393
1.06
1.28
3.1
3.2
u/l
52.0
52.6
0.08
2117
20599
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
62
1.94
1.27
1.3
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
78
615
1.27
1.27
1.6
1.5
g/l
30.8
32.0
0.40
71
556
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
102
830
1.23
1.27
1.4
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
42
302
1.39
1.27
1.3
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
9
44
2.05
1.26
1.1
1.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
28
186
1.51
1.26
2.4
2.5
ml
1837.8
1920.9
0.16
23
160
(40760888) Immunoglobulin light chains.free panel - Serum
84
1047
0.80
1.26
3.7
3.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
25
162
1.55
1.25
2.9
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
25
162
1.55
1.25
2.9
1.8
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
85
680
1.25
1.24
1.3
1.5
pmol/l
92.3
218.9
3.24
85
662
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
9
45
2.00
1.23
6.7
5.1
ug/min
78.0
60.1
—
9
39
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
493
4526
1.10
1.22
1.7
1.8
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
10
49
2.04
1.22
1.1
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
339
3053
1.12
1.21
4.1
4.1
%
0.1
0.1
0.03
96
890
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
28
188
1.49
1.21
1.2
1.1
u/l
22.3
30.0
0.39
23
139
(3019977) pH of Arterial blood
14
239
0.58
1.21
1.3
2.5
ph
7.4
7.4
—
5
83
(1002224) Polysomnography panel
139
1174
1.19
1.20
1.1
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
25
164
1.53
1.20
2.9
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
337
3037
1.12
1.19
3.6
2.7
ml/min/173m2
58.4
63.2
1.55
136
1268
(3025315) Body weight
6
26
2.31
1.18
6.0
4.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
37
264
1.40
1.18
1.2
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
30
206
1.46
1.17
1.3
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
61
472
1.30
1.17
1.4
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
22
141
1.56
1.17
1.1
1.2
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
11
57
1.93
1.17
1.5
1.4
%
18.7
17.1
—
6
39
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
88
713
1.24
1.16
1.8
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
221
1944
1.14
1.15
1.2
1.3
u/ml
136.6
211.8
2.23
206
1781
(3012441) Differential panel - Pleural fluid
61
473
1.29
1.15
1.6
1.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
39
2.05
1.15
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
22
142
1.55
1.14
1.1
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
234
2072
1.14
1.12
2.5
2.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
354
3214
1.11
1.11
4.0
4.0
%
1.1
0.9
0.53
103
958
(3037692) Legionella sp identified in Specimen by Organism specific culture
21
135
1.56
1.11
1.5
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
411
3762
1.10
1.10
2.1
2.2
ug/g
143.1
149.7
0.10
327
2949
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
66
1.82
1.09
1.2
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
41
1.95
1.08
1.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
47
355
1.33
1.08
1.1
1.1
—
2.7
—
0
6
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
506
5462
0.92
1.08
1.2
1.2
u/ml
11.8
13.4
0.19
177
2032
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
15
89
1.69
1.07
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
35
253
1.39
1.06
1.3
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
403
3694
1.10
1.06
4.5
3.7
mmol/l
1.7
2.0
0.76
337
2991
(3021960) Folate [Moles/volume] in Serum or Plasma
982
9332
1.07
1.04
1.6
1.6
nmol/l
20.4
20.3
0.09
829
7918
(3016750) Collection duration of Urine
33
237
1.40
1.04
2.6
2.1
min
479.7
491.7
0.22
23
175
(3016650) Hepatitis A virus Ab [Presence] in Serum
65
517
1.26
1.03
1.1
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
65
517
1.26
1.03
1.2
1.3
nmol/l
0.2
0.3
—
9
33
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
22
2.27
1.03
2.2
1.5
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
22
2.27
1.03
1.4
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
22
2.27
1.03
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
34
246
1.39
1.03
1.2
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
885
9331
0.94
1.03
3.5
3.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
46
350
1.32
1.02
1.4
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
93
771
1.21
1.02
1.3
1.2
mmol/l
3.6
3.9
1.44
86
718
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
68
546
1.25
1.01
1.3
1.2
u/ml
262.2
288.5
0.38
45
331
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
43
325
1.33
1.00
1.4
1.5
nmol/l
0.2
0.3
0.12
35
241
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
107
901
1.19
1.00
2.0
1.8
mg/l
12.0
11.6
0.25
101
821
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
64
511
1.26
0.99
1.2
1.3
nmol/l
0.7
0.6
0.32
59
486
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
19
123
1.55
0.99
1.7
2.1
e6/l
40508.7
19505.4
—
10
73
(3033799) Differential panel - Peritoneal fluid
18
115
1.57
0.99
2.2
2.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
34
248
1.37
0.99
1.2
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
51
396
1.29
0.99
2.0
1.6
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
5
23
2.18
0.98
4.2
3.4
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
0
30
0.00
0.97
0.0
1.2
—
0.1
—
0
18
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1230
11798
1.06
0.97
4.6
4.6
%
22.1
22.0
0.11
682
6101
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
54
1.85
0.96
1.1
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
23
157
1.47
0.95
1.2
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
315
2870
1.11
0.95
4.0
4.1
%
0.2
0.3
0.44
83
748
(3028300) Cannabinoids [Presence] in Urine
44
569
0.77
0.95
4.6
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
16
246
0.65
0.94
10.3
2.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
109
926
1.18
0.94
3.6
2.8
mg/l
1.6
1.7
0.03
103
838
(3009466) Valproate [Moles/volume] in Serum or Plasma
37
489
0.75
0.94
4.1
4.9
umol/l
325.4
347.8
0.35
28
419
(3016879) Cocaine [Presence] in Urine
40
522
0.76
0.93
4.9
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
44
565
0.78
0.91
4.6
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
44
565
0.78
0.91
4.6
1.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
19
126
1.51
0.91
1.1
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
108
921
1.18
0.90
1.2
1.2
titre
602.9
89.7
—
7
67
(3048929) Epstein Barr virus Ab [Presence] in Serum
94
793
1.19
0.89
1.2
1.2
—
—
—
0
0
(4268621)
43
332
1.30
0.89
2.5
2.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1535
14847
1.05
0.88
3.0
2.9
ug/l
147.3
146.9
0.02
1392
13612
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
8
42
1.91
0.88
2.0
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
540
5758
0.93
0.88
1.3
1.3
iu/ml
31.9
36.6
0.41
146
1783
(3024928) Oxygen saturation in Venous blood
98
831
1.18
0.88
3.0
2.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
400
3704
1.09
0.87
4.5
3.7
kpa
5.9
5.8
0.49
388
3593
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
18
265
0.68
0.87
1.1
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
50
395
1.27
0.87
3.8
3.5
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
30
2.00
0.87
1.5
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
389
3600
1.09
0.86
2.6
2.5
e9/l
70.5
68.9
0.32
268
2742
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
183
1629
1.13
0.86
2.0
2.4
g/l
3.6
3.8
1.94
131
1165
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
99
843
1.18
0.85
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
99
843
1.18
0.85
1.3
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
183
1631
1.13
0.84
2.0
2.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
17
112
1.52
0.84
2.1
2.1
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
13
80
1.63
0.84
1.6
1.5
%
10.6
6.2
—
5
40
(3043410) Blood group antigens tested for on Red Blood Cells
16
104
1.54
0.84
1.6
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
183
1632
1.13
0.84
2.0
2.4
g/l
7.1
7.4
1.96
134
1213
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
40
309
1.30
0.83
1.4
1.5
u/ml
40.1
22.8
—
8
65
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
58
470
1.24
0.83
1.1
1.3
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
20
285
0.70
0.83
1.0
1.0
ng/l
283.7
315.9
0.17
13
190
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
28
205
1.37
0.83
2.7
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
28
205
1.37
0.83
2.7
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
28
205
1.37
0.83
2.7
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
28
205
1.37
0.83
2.7
1.7
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
46
1.74
0.82
1.4
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
44
556
0.79
0.82
3.7
1.7
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
27
365
0.74
0.82
1.0
1.1
u/ml
0.5
1.2
—
9
148
(3013139) Helicobacter pylori Ag [Presence] in Stool
208
2306
0.90
0.81
1.1
1.2
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
6
32
1.88
0.81
1.2
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
135
1183
1.15
0.81
1.3
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
33
432
0.76
0.81
1.0
1.1
u/ml
1.2
1.7
0.30
13
174
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
52
418
1.25
0.80
1.3
1.4
u/l
484.3
322.1
0.99
52
398
(3051387) C reactive protein [Mass/volume] in Capillary blood
69
828
0.83
0.80
2.9
3.6
mg/l
25.9
28.4
0.26
42
521
(40768797) Stomach Pathology biopsy report
548
5158
1.07
0.80
1.3
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
329
3559
0.92
0.79
1.7
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
41
321
1.28
0.79
1.8
1.7
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
8
48
1.67
0.78
2.0
2.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
28
373
0.75
0.78
1.1
1.1
u/ml
3.0
3.0
0.01
13
175
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
310
2856
1.09
0.78
1.5
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
12
187
0.64
0.78
1.1
1.2
nmol/l
136.7
136.8
0.01
12
187
(3027456) Digoxin [Moles/volume] in Serum or Plasma
104
898
1.16
0.77
3.7
3.1
nmol/l
0.8
0.8
0.15
81
664
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
34
1.77
0.76
1.0
1.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
373
3469
1.08
0.76
2.7
2.6
g/l
65.9
66.2
0.30
334
3151
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
27
200
1.35
0.76
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
27
200
1.35
0.76
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
161
0.62
0.75
1.0
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
326
3518
0.92
0.75
1.5
1.7
%
1.5
1.5
0.06
278
3045
(4034850)
104
1196
0.87
0.74
9.3
10.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
54
1.67
0.74
1.3
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
47
378
1.25
0.74
1.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
82
960
0.85
0.74
1.5
1.7
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
12
184
0.65
0.73
1.2
1.3
mmol/l
5.9
6.1
0.23
12
175
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
253
2318
1.10
0.73
1.8
1.8
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
9
55
1.64
0.73
1.1
1.1
—
—
—
0
0
(44806420)
8
133
0.60
0.73
2.3
2.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
8
134
0.60
0.73
16.3
12.5
nmol/l
1046.5
844.6
—
8
127
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
254
2329
1.10
0.72
1.4
1.5
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
391
3652
1.08
0.72
2.4
2.4
ug/l
7.4
7.1
0.10
333
3172
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
39
1.80
0.72
1.1
2.2
umol/l
13.7
18.6
—
7
39
(3023383) Lactate [Moles/volume] in Pleural fluid
20
142
1.41
0.72
1.2
1.4
mmol/l
3.2
3.3
0.08
20
128
(3020891) Body temperature
181
1632
1.11
0.72
5.4
4.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
104
905
1.15
0.72
3.6
4.9
mmol/l
2.5
2.7
0.28
69
630
(3003338) MCHC [Mass/volume]
2929
28857
1.05
0.71
24.4
20.6
g/l
331.7
331.9
0.86
2914
28609
(3050129) First trimester maternal screen panel - Serum or Plasma
44
353
1.25
0.71
1.5
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
40
1.75
0.71
1.3
1.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
7
40
1.75
0.71
1.1
1.1
g/l
15.6
16.9
—
7
33
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
21
287
0.73
0.71
1.0
1.0
ng/l
34.4
44.1
0.64
14
188
(44790048)
53
435
1.22
0.70
1.4
1.5
—
—
—
0
0
(44790047)
53
435
1.22
0.70
1.4
1.5
—
—
—
0
0
(44790049)
53
435
1.22
0.70
1.4
1.5
—
—
—
0
0
(44806118)
53
435
1.22
0.70
1.4
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
27
203
1.33
0.70
2.6
2.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
24
177
1.36
0.70
1.1
1.1
u/l
1.1
1.2
0.37
13
89
(21494434) Karyotype in Bone marrow
29
377
0.77
0.70
1.3
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
15
101
1.49
0.70
2.5
1.7
ug/l
1.2
1.2
0.07
15
93
(3008898) HLA-B27 [Presence]
82
954
0.86
0.69
1.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
9
143
0.63
0.69
1.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
40
319
1.26
0.69
1.3
1.5
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
21
285
0.74
0.68
1.0
1.0
ng/l
488.3
699.0
2.15
12
186
(3027945) Reticulocytes/100 erythrocytes in Blood
503
4752
1.07
0.68
2.5
2.4
%
1.8
1.8
0.65
443
4178
(3000570) Elastase.pancreatic [Mass/mass] in Stool
126
1117
1.13
0.67
1.4
1.4
ug/g
290.8
271.6
0.58
85
657
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
169
1525
1.11
0.67
2.1
2.4
g/l
9.7
10.3
0.93
135
1285
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
156
1402
1.12
0.67
2.2
2.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
184
1669
1.11
0.67
1.5
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
101
883
1.15
0.67
1.3
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
92
0.54
0.67
1.2
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
93
0.54
0.66
3.8
7.7
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
15
214
0.70
0.66
1.2
1.4
pmol/l
92.6
184.7
—
5
73
(3032773) Endomysium IgG Ab [Titer] in Serum
17
237
0.72
0.66
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
32
250
1.28
0.65
1.3
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
21
282
0.74
0.65
1.0
1.1
u/ml
0.7
2.1
—
6
109
(3023430) Cat dander IgE Ab [Units/volume] in Serum
19
259
0.73
0.64
1.0
1.1
u/ml
1.3
2.6
—
7
102
(3012544) pH of Venous blood
408
3837
1.07
0.64
4.3
3.7
—
7.4
—
0
22
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
25
189
1.32
0.64
1.3
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
182
1999
0.91
0.64
3.0
3.5
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
5
29
1.72
0.64
1.0
1.0
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
8
128
0.62
0.63
1.0
1.0
—
3.3
—
0
20
(3025941) Bacteria identified in Stool by Culture
204
1868
1.10
0.63
1.2
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
81
701
1.16
0.62
1.3
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
35
436
0.80
0.62
5.3
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
22
164
1.34
0.62
1.1
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
17
234
0.73
0.62
1.5
1.3
u/ml
0.3
1.3
—
8
116
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
8
49
1.63
0.62
2.0
2.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
64
750
0.85
0.61
1.2
1.2
—
261.1
—
0
19
(3023487) Leukocytes [#/volume] in Peritoneal fluid
19
139
1.37
0.60
1.8
2.3
e6/l
28789.4
835.0
—
10
105
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
48
399
1.21
0.59
3.9
2.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
27
210
1.29
0.58
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
264
2456
1.08
0.58
2.9
3.2
e9/l
4.2
4.2
0.00
188
1831
(3010421) pH of Blood
119
1065
1.12
0.57
4.1
4.6
ph
7.4
7.4
0.49
103
891
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1020
9875
1.04
0.57
2.2
2.3
mg/l
3.0
3.0
0.07
871
8406
(3010726) Horse dander IgE Ab [Units/volume] in Serum
26
330
0.79
0.56
1.0
1.1
u/ml
0.1
1.7
—
5
82
(3008295) Osmolality of Serum or Plasma
47
393
1.20
0.55
1.4
1.4
mosm/kgh2o
283.7
276.9
1.80
41
294
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
33
407
0.81
0.55
1.2
1.3
mmol/l
7.0
7.6
0.51
26
299
(3051651) Icteric interference index of Serum or Plasma
28
221
1.27
0.55
4.4
3.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
19
251
0.76
0.55
1.5
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
18
133
1.35
0.55
2.2
1.6
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
20
262
0.76
0.54
1.1
1.3
promille
2.0
1.2
1.00
12
204
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
58
496
1.17
0.54
1.7
1.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
9
61
1.48
0.53
1.2
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
108
967
1.12
0.53
1.7
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
105
939
1.12
0.53
1.7
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
79
694
1.14
0.52
1.5
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1189
11567
1.04
0.52
3.0
3.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
58
498
1.17
0.52
1.7
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
96
0.62
0.52
1.0
1.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
9
136
0.66
0.51
1.0
1.1
%
98.9
92.5
—
9
106
(1616796) Gas panel - Central venous blood
102
914
1.12
0.50
3.1
4.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
97
867
1.12
0.50
2.0
2.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
84
1.43
0.49
1.9
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
63
548
1.15
0.49
1.3
1.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
107
0.65
0.48
3.7
7.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
82
922
0.89
0.48
2.3
3.0
kpa
7.9
8.0
0.10
74
856
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
13
93
1.40
0.48
1.0
1.1
—
—
—
0
0
(4015189)
7
111
0.63
0.48
2.0
2.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1794
17609
1.03
0.47
4.7
5.1
estimate
0.0
0.0
0.50
357
3332
(3001964) Herpes simplex virus Ag [Presence] in Specimen
14
102
1.37
0.47
1.7
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
39
327
1.19
0.47
1.6
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
56
485
1.16
0.47
1.3
1.2
u/ml
6.2
5.2
0.15
24
207
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
97
872
1.11
0.47
3.6
3.3
u/ml
130.8
902.0
1.64
89
802
(3035947) Staphylolysin Ab [Units/volume] in Serum
14
188
0.74
0.46
1.0
1.2
—
3.9
—
0
9
(3003129) Base excess in Capillary blood by calculation
15
111
1.35
0.46
1.3
2.0
mmol/l
-0.7
0.8
0.84
15
102
(3025468) Yersinia sp identified in Specimen by Organism specific culture
57
495
1.15
0.46
1.7
1.4
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
14
187
0.75
0.45
1.1
1.2
u/l
513.5
316.5
0.33
14
173
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
74
833
0.89
0.45
1.5
1.8
nmol/l
44.0
43.5
0.06
74
798
(3004451) EKG impression Narrative
26
210
1.24
0.45
1.4
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1154
11257
1.03
0.44
3.0
3.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
13
175
0.74
0.44
1.4
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
86
1.40
0.44
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
36
427
0.84
0.44
3.5
3.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
17
219
0.78
0.43
1.6
1.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
232
2468
0.94
0.43
3.1
3.1
g/l
126.7
127.9
0.34
224
2400
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
207
0.77
0.42
1.0
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
49
564
0.87
0.42
1.4
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
93
0.64
0.42
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
93
0.64
0.42
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
93
0.64
0.42
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
93
0.64
0.42
1.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
27
221
1.22
0.42
1.4
1.7
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
5
32
1.56
0.42
1.0
1.2
u/ml
0.0
0.1
—
5
16
(3044009) aPTT.lupus sensitive (LA screen)
5
32
1.56
0.42
1.2
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
28
338
0.83
0.42
1.1
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
491
4718
1.05
0.41
6.4
6.9
mmol/l
0.8
1.1
0.86
396
3627
(3019309) Folate [Moles/volume] in Red Blood Cells
796
7726
1.04
0.41
1.8
1.8
nmol/l
1158.9
1170.5
0.12
582
5767
(3019174) dRVVT (LA screen)
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
33
1.52
0.41
10.0
4.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
38
323
1.18
0.41
1.8
1.7
mg/l
5.4
4.5
0.34
38
309
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
17
217
0.78
0.41
3.0
3.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
37
434
0.85
0.41
1.6
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
13
172
0.76
0.40
1.1
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
25
204
1.23
0.40
1.3
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
25
204
1.23
0.40
1.3
1.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
16
205
0.78
0.40
1.0
1.2
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
12
88
1.36
0.40
1.8
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
26
214
1.22
0.39
8.1
13.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
35
1.43
0.39
1.2
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
48
549
0.87
0.39
1.0
1.1
iu/ml
38.8
81.1
—
10
118
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
187
1.23
0.38
1.1
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
63
561
1.12
0.38
1.3
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
56
495
1.13
0.38
1.8
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
12
89
1.35
0.37
2.2
3.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
132
1223
1.08
0.37
1.6
1.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
491
4733
1.04
0.37
6.4
6.9
kpa
12.7
12.1
1.90
470
4504
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
491
4734
1.04
0.37
6.4
6.9
kpa
5.0
5.1
0.75
471
4502
(3009261) Glucose [Presence] in Urine by Test strip
1812
17849
1.03
0.36
3.6
3.8
estimate
0.0
0.0
1.34
347
3230
(3024354) Oxygen [Partial pressure] in Venous blood
317
3028
1.05
0.36
3.4
3.0
kpa
4.7
4.5
0.57
304
2929
(21494755) Public health laboratory ask at order entry panel
208
2202
0.94
0.36
1.4
1.4
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
33
385
0.86
0.35
1.1
1.1
u/ml
1.5
2.7
0.74
14
146
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
19
153
1.24
0.35
1.1
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
58
649
0.89
0.35
1.9
1.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
125
0.72
0.35
1.2
2.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
125
0.72
0.35
1.2
2.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
9
126
0.71
0.35
1.4
1.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
126
0.71
0.35
3.1
1.9
ug/l
46.6
56.6
—
9
121
(3000034) Microalbumin [Mass/volume] in Urine
32
373
0.86
0.34
3.3
3.1
mg/l
15.4
32.9
1.31
22
287
(3039162) Centromere protein B Ab [Units/volume] in Serum
44
386
1.14
0.34
1.1
1.2
—
53.8
—
0
21
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
19
154
1.23
0.33
1.1
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1217
12404
0.97
0.33
4.2
4.0
mg/mmol
6.5
9.4
1.79
739
7882
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
275
0.84
0.33
1.0
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
46
1.30
0.33
1.5
1.7
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
86
0.70
0.33
1.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
55
614
0.89
0.33
1.4
1.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
38
331
1.15
0.33
1.3
1.4
—
25.5
—
0
17
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
29
247
1.18
0.32
1.8
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
178
1679
1.06
0.32
1.6
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
87
798
1.09
0.32
1.4
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
47
1.28
0.32
1.2
1.1
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
10
74
1.35
0.32
1.1
1.3
—
99.8
—
0
12
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
16
198
0.81
0.32
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
15
187
0.80
0.32
1.1
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
17
137
1.24
0.32
1.5
2.2
umol/l
118.2
144.5
—
10
81
(3036071) Salmonella sp Ab [Titer] in Serum
12
92
1.31
0.31
1.0
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
96
1038
0.92
0.31
1.6
1.6
iu/ml
0.1
9.4
0.94
19
229
(3042631) Mycobacterium sp identified in Specimen
62
561
1.11
0.31
2.1
2.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
56
504
1.11
0.30
1.8
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
140
1314
1.07
0.30
1.5
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
19
229
0.83
0.30
2.3
1.8
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
102
1.28
0.30
1.2
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
73
796
0.92
0.29
2.1
2.9
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
18
148
1.22
0.29
1.6
1.5
%
3.6
2.7
0.12
12
125
(3023183) Ammonium ion [Moles/volume] in Plasma
89
823
1.08
0.29
2.3
2.7
umol/l
33.8
35.4
0.21
70
693
(3029937) Albumin [Presence] in Urine by Test strip
947
9662
0.97
0.29
4.1
4.2
estimate
0.0
0.0
1.08
333
3174
(3034860) Kappa light chains.free [Mass/volume] in Serum
130
1384
0.94
0.29
3.4
3.3
mg/l
47.1
102.2
0.73
108
1123
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
55
607
0.90
0.28
1.7
1.9
pmol/l
187.1
197.0
0.32
50
573
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
130
1382
0.94
0.28
3.4
3.3
mg/l
72.5
61.1
0.13
109
1126
(3003740) Influenza virus B Ag [Presence] in Specimen
44
393
1.12
0.28
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
94
1.28
0.28
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
94
1.28
0.28
1.2
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
17
140
1.22
0.27
1.5
2.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
28
322
0.87
0.27
1.6
2.1
u/field
2.8
1.7
0.32
14
122
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
116
0.78
0.27
1.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
55
499
1.10
0.27
1.8
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
44
394
1.12
0.27
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
237
2473
0.96
0.27
2.9
3.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
13
104
1.25
0.26
3.7
2.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
13
104
1.25
0.26
1.2
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
34
300
1.13
0.26
1.6
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
260
2498
1.04
0.26
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
196
1871
1.05
0.26
1.7
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
41
367
1.12
0.26
1.2
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
174
1657
1.05
0.25
1.8
2.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
9
75
1.20
0.25
3.0
1.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
9
76
1.18
0.24
2.2
1.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
169
1611
1.05
0.24
1.6
1.6
u/ml
3.4
21.7
—
6
41
(37021550) Renin [Units/volume] in Plasma --upright
11
87
1.27
0.24
1.6
1.3
mu/l
53.7
62.0
0.09
11
65
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
77
1.17
0.24
1.3
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
47
517
0.91
0.24
1.4
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
97
910
1.07
0.23
1.8
1.7
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
21
180
1.17
0.23
1.6
1.5
%
56.7
66.1
0.54
15
146
(3009508) Creatinine [Moles/volume] in Urine
1193
12104
0.98
0.23
3.4
3.2
mmol/l
7.2
7.4
0.82
990
10075
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
163
1555
1.05
0.23
3.8
4.0
mmol/l
24.6
24.8
0.39
145
1421
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
13
106
1.23
0.23
1.5
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
105
989
1.06
0.23
2.5
2.4
ug/min
55.7
102.1
1.07
63
604
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
39
1.28
0.23
1.4
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
682
6959
0.98
0.22
1.3
1.2
u/ml
1.8
1.8
0.02
156
1780
(3018133) Calcium [Moles/volume] in Urine
5
40
1.25
0.22
2.2
2.0
mmol/l
2.6
3.0
—
5
35
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
15
125
1.20
0.22
1.1
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
23
200
1.15
0.22
2.3
1.5
u/l
5.4
7.1
0.84
16
173
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
44
483
0.91
0.22
1.7
1.5
%
55.5
61.3
0.38
26
302
(3010503) CD19 cells [#/volume] in Blood
25
219
1.14
0.22
2.8
2.3
e9/l
0.1
0.2
0.84
25
209
(3044927) Protein electrophoresis panel - Urine
40
441
0.91
0.22
1.3
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
49
449
1.09
0.21
1.3
1.6
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
26
294
0.88
0.21
1.3
1.1
—
47.2
—
0
25
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
42
1.19
0.21
1.0
1.2
umol/24h
2.2
1.8
—
5
42
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
4.3
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.4
—
2.0
—
0
10
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
1.8
—
0
10
(3028026) IgM [Mass/volume] in Serum or Plasma
203
2110
0.96
0.21
1.8
1.9
g/l
1.3
1.4
0.32
175
1907
(3006969) Lambda light chains [Mass/volume] in Urine
0
12
0.00
0.21
0.0
1.1
—
0.0
—
0
6
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
0.2
—
0
12
(4281824)
40
363
1.10
0.21
1.2
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
120
1263
0.95
0.21
1.1
1.2
u/ml
0.3
1.1
—
7
118
(3048879) Bone marrow aspiration report
15
126
1.19
0.21
2.1
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
46
421
1.09
0.21
1.5
1.5
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.7
—
13.8
—
0
13
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
20
173
1.16
0.20
1.2
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
37
335
1.11
0.20
2.6
2.2
ml
636.8
634.6
0.01
24
216
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
43
470
0.91
0.20
1.2
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1776
17592
1.02
0.20
3.5
3.8
estimate
0.0
0.0
0.50
348
3297
(3014148) Varicella zoster virus Ab [Titer] in Serum
28
313
0.89
0.20
1.1
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
26
292
0.89
0.20
1.3
1.1
—
58.3
—
0
12
(3006462) Nitrate [Presence] in Urine
22
193
1.14
0.19
4.2
3.7
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
129
1350
0.95
0.19
3.4
3.3
ratio
1.1
2.7
—
8
107
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
52
1.15
0.19
1.0
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
401
3915
1.03
0.19
7.2
7.7
g/l
120.5
121.0
0.18
391
3767
(3000475) Leukocytes [#/volume] in Synovial fluid
99
939
1.06
0.19
1.6
1.6
e6/l
10887.8
13211.4
0.40
69
676
(3045424) Erythrocytes [Presence] in Urine
58
622
0.93
0.18
1.4
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
119
1246
0.95
0.18
1.5
1.6
titre
116.7
300.0
—
6
61
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
40
367
1.09
0.18
1.6
1.4
%
37.4
29.6
0.54
23
223
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
462
4524
1.02
0.17
1.4
1.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
7
60
1.17
0.17
2.3
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
21
237
0.89
0.17
1.0
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
66
702
0.94
0.17
1.4
1.3
mmol/l
59.6
62.2
0.19
53
564
(3044941) Cell count panel - Synovial fluid
66
620
1.07
0.17
1.3
1.4
—
—
—
0
0
(4146454)
49
455
1.08
0.17
2.8
2.7
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
27
243
1.11
0.17
2.1
2.2
%
19.2
14.8
—
10
99
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
15
129
1.16
0.17
3.1
2.0
ug/l
15.4
80.7
0.55
15
116
(3016228) CD19 cells/100 cells in Blood
17
148
1.15
0.16
1.5
2.1
%
7.9
8.7
0.12
17
140
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
21
236
0.89
0.16
1.0
1.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
101
1.19
0.16
1.2
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
16
139
1.15
0.16
2.7
2.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
92
1.20
0.16
1.2
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1164
11765
0.99
0.16
3.4
3.3
mg/l
378.5
325.4
0.15
712
7498
(3035933) Granulocytes/100 leukocytes in Blood
8
72
1.11
0.16
1.3
1.8
—
—
—
0
0
(3017704) Immunofixation for Urine
21
235
0.89
0.16
1.4
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
13
111
1.17
0.15
1.0
1.3
—
—
—
0
0
(4133840)
8
73
1.10
0.15
1.1
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
6
76
0.79
0.15
1.7
2.8
au/ml
—
65.4
—
0
11
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
77
0.78
0.15
1.3
2.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
22
245
0.90
0.15
1.3
1.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
119
0.84
0.15
1.4
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
157
1517
1.04
0.15
1.4
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
20
178
1.12
0.15
1.2
1.3
—
1.4
—
0
10
(4024509)
35
379
0.92
0.15
1.3
1.7
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
123
1278
0.96
0.15
1.1
1.1
—
1.4
—
0
15
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
57
537
1.06
0.14
1.7
2.3
pg
33.6
32.8
0.70
57
532
(3020650) Glucose [Presence] in Urine
7
86
0.81
0.14
1.1
1.5
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
19
169
1.12
0.14
5.7
6.0
u/ml
788.0
53.0
—
5
41
(3030981) Hyaline casts [#/volume] in Urine by Automated count
203
2088
0.97
0.14
2.8
2.9
e6/l
0.2
0.3
1.39
198
2041
(3037522) Nuclear Ab [Titer] in Serum
443
4510
0.98
0.14
1.3
1.3
titre
507.1
510.0
0.01
90
970
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
22
198
1.11
0.14
1.6
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
22
198
1.11
0.14
1.6
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
56
593
0.94
0.14
1.1
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
53
562
0.94
0.13
1.2
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
100
0.80
0.13
1.1
1.5
ug/l
6.3
8.8
—
8
100
(44813793)
18
201
0.90
0.13
1.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
22
199
1.11
0.13
4.8
2.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
71
745
0.95
0.13
1.5
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
11
94
1.17
0.13
1.6
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
104
1079
0.96
0.12
2.3
3.2
mmol/l
24.5
24.9
0.42
90
945
(3041918) Cholesterol [Moles/volume] in Pleural fluid
10
85
1.18
0.12
1.1
1.2
mmol/l
1.1
1.6
—
5
55
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
201
2060
0.97
0.12
1.3
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
191
1863
1.03
0.12
3.1
2.5
%
1.2
1.2
0.04
191
1850
(3032057) Clostridioides difficile [Presence] in Stool
11
95
1.16
0.11
1.7
2.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
43
456
0.94
0.11
2.7
21.3
mmol/l
6.5
7.4
1.38
32
383
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
16
143
1.12
0.11
1.2
1.1
ng/l
88.8
436.6
—
5
38
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
38
357
1.06
0.11
1.1
1.3
nmol/l
1.3
1.5
0.41
33
320
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
52
494
1.05
0.11
1.3
1.2
u/ml
1.6
3.6
1.56
13
162
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
86
1.16
0.11
1.1
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
54
514
1.05
0.11
1.7
1.6
g/l
0.5
0.9
2.68
44
393
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
101
1044
0.97
0.10
1.6
1.7
mg/l
3.0
3.6
0.35
73
749
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
115
0.87
0.10
1.0
1.1
miu/ml
1778.1
1689.0
—
10
115
(3024139) IgG subclass 3 [Mass/volume] in Serum
30
321
0.93
0.10
1.4
1.4
g/l
0.8
0.4
0.44
22
228
(3028192) IgG subclass 2 [Mass/volume] in Serum
30
321
0.93
0.10
1.4
1.4
g/l
2.4
3.0
1.06
22
228
(3027135) IgG subclass 1 [Mass/volume] in Serum
30
321
0.93
0.10
1.4
1.4
g/l
8.0
6.9
0.37
22
229
(1175426) CD3 cells/100 lymphocytes in Blood
27
251
1.08
0.10
2.2
2.2
%
64.8
71.6
1.06
27
234
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
150
1537
0.98
0.09
1.0
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
967
9597
1.01
0.09
1.6
1.6
mmol/l
1.3
1.4
0.88
778
8004
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
54
517
1.05
0.09
1.8
1.9
u/l
1193.2
3730.6
1.02
15
207
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
20
184
1.09
0.09
1.0
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
35
370
0.95
0.09
1.2
1.1
—
2.8
—
0
7
(3036670) Protein [Mass/volume] in Synovial fluid
14
126
1.11
0.09
1.4
1.2
g/l
38.0
39.0
—
9
62
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
55
1.09
0.08
1.5
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
75
725
1.04
0.08
2.0
1.6
nmol/l
0.8
0.8
0.11
64
599
(3011412) CD3 cells [#/volume] in Blood
34
322
1.06
0.08
3.0
2.2
e9/l
0.9
1.1
0.52
20
195
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
5
65
0.77
0.08
1.0
1.1
—
5.1
—
0
8
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
65
0.77
0.08
1.8
1.6
ng/l
147.8
152.5
—
5
65
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
65
1.08
0.08
1.1
1.7
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
50
480
1.04
0.08
1.0
1.1
g/l
1.4
1.5
2.07
45
425
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
65
628
1.04
0.07
1.2
1.2
u/ml
46.9
40.8
—
6
71
(3035320) C reactive protein [Mass/volume] in Body fluid
24
256
0.94
0.07
2.8
2.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
45
431
1.04
0.07
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
94
915
1.03
0.07
1.5
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
68
702
0.97
0.07
1.8
1.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
77
1.04
0.07
1.1
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
319
3229
0.99
0.07
3.4
3.5
—
—
—
0
0
(3000492) Spirometry study
317
3132
1.01
0.07
1.5
1.5
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
19
204
0.93
0.07
1.5
1.3
nmol/l
1.2
1.2
—
10
157
(40757373) Influenza virus identified in Isolate
9
87
1.03
0.07
2.1
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
88
1.02
0.07
1.2
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
171
1739
0.98
0.06
1.8
1.9
ug/l
2.2
2.4
0.06
144
1520
(3020491) Glucose [Moles/volume] in Blood
29
275
1.05
0.06
2.4
2.3
mmol/l
7.9
6.8
0.77
20
180
(3007164) IgA [Mass/volume] in Serum or Plasma
624
6193
1.01
0.06
1.5
1.5
g/l
2.2
2.6
5.24
350
3696
(3011648) Oxygen content in Venous blood
32
305
1.05
0.06
1.5
1.9
%
10.7
10.9
0.06
32
305
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
88
859
1.02
0.06
1.6
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
34
325
1.05
0.06
1.4
1.1
u/ml
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
21
223
0.94
0.06
1.3
1.5
g/l
1.0
0.9
0.58
21
223
(40767503) Oxygen content in Capillary blood by calculation
88
899
0.98
0.05
2.3
2.6
%
15.6
16.0
0.43
49
463
(21494890) Protein electrophoresis panel - 24 hour Urine
47
455
1.03
0.05
1.9
2.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
36
374
0.96
0.05
1.3
1.3
e6/l
130994.5
94890.9
0.12
31
260
(3024263) Appearance of Synovial fluid
21
222
0.95
0.05
2.4
1.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
73
713
1.02
0.05
1.3
1.2
—
7.9
—
0
7
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
10
110
0.91
0.05
3.3
2.1
%
31.4
29.4
—
10
101
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
11
120
0.92
0.05
1.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
10
91
1.10
0.04
1.1
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
221
2232
0.99
0.04
8.8
9.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
36
348
1.03
0.04
1.0
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
133
1347
0.99
0.03
3.2
3.0
g/l
0.2
0.3
1.48
71
536
(4211845)
22
210
1.05
0.03
4.2
3.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
240
0.96
0.03
3.0
2.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
24
250
0.96
0.03
1.3
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
62
632
0.98
0.03
1.2
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
256
2542
1.01
0.03
3.3
3.7
ph
7.4
7.4
0.22
35
321
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
366
3680
0.99
0.03
2.2
3.0
ng/l
243.0
218.1
0.42
326
3361
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
106
1073
0.99
0.02
1.4
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
293
2913
1.01
0.02
2.5
2.4
—
—
—
0
0
(4306422)
48
471
1.02
0.02
1.3
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
15
143
1.05
0.01
8.7
1.9
%
129.9
164.7
1.09
15
131
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
18
173
1.04
0.01
2.0
1.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
21
203
1.03
0.01
1.6
1.7
umol/l
10.4
9.2
0.10
16
132
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
67
663
1.01
0.01
1.2
1.2
u/l
92.2
37.1
0.73
59
573
(3024471) HLA-A [Type]
10
94
1.06
0.01
1.0
1.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
93
923
1.01
0.01
1.8
2.2
g/l
124.8
128.2
0.64
69
672
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
99
997
0.99
0.01
1.8
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
12
126
0.95
0.00
1.1
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
184
1833
1.00
0.00
3.7
3.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
32
314
1.02
0.00
1.2
1.2
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
36
354
1.02
0.00
2.4
2.0
—
1.1
—
0
16
(3011288) Drugs identified in Urine by Screen method
36
366
0.98
0.00
8.3
2.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
65
656
0.99
0.00
1.1
1.3
miu/ml
249.0
203.8
0.40
30
275
(3028271) Lactate [Moles/volume] in Capillary blood
67
664
1.01
0.00
1.8
1.9
mmol/l
1.6
1.7
0.45
62
649
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
84
834
1.01
0.00
1.2
1.2
u/ml
2.2
6.7
—
6
89
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
108
1.02
0.00
1.1
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
13
132
0.98
0.00
1.3
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
22
218
1.01
0.00
1.3
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
48
485
0.99
0.00
1.3
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
86
855
1.01
0.00
1.2
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
114
0.96
0.00
1.0
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
246
2455
1.00
0.00
3.2
3.6
mmol/l
1.5
1.8
0.76
178
1796
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
258
2575
1.00
0.00
3.3
3.7
kpa
5.0
5.1
2.33
239
2380
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
11
107
1.03
0.00
1.2
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
27
266
1.02
0.00
1.6
1.4
—
—
—
0
0
(4062490)
32
323
0.99
0.00
1.4
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
85
846
1.00
0.00
1.2
1.2
u/ml
2.0
6.6
—
7
152
(4094501)
101
1006
1.00
0.00
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
103
1026
1.00
0.00
1.5
1.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
125
1254
1.00
0.00
5.0
3.9
mmol/l
3.9
3.9
0.12
118
1167
(40761539) Cells [Type] in Urine sediment by Light microscopy
10
101
0.99
0.00
1.2
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
27
269
1.00
0.00
1.6
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
29
291
1.00
0.00
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
56
561
1.00
0.00
1.3
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
266
2663
1.00
0.00
2.9
2.7
g/l
10.0
10.6
0.90
235
2421
(3016502) Oxygen saturation in Arterial blood
427
4271
1.00
0.00
7.0
7.2
%
96.2
95.4
2.73
412
4108
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
8
0.00
0.00
0.0
6.2
—
50.9
—
0
8
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
7
69
1.01
0.00
7.0
6.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
9
90
1.00
0.00
1.0
1.2
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
120
1.00
0.00
1.8
2.2
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
123.0
—
0
7
(3008116) Ketones [Moles/volume] in Urine by Test strip
9
89
1.01
0.00
1.3
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
99
0.91
0.00
1.0
1.1
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
84
0.95
0.00
1.1
1.3
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
11
110
1.00
0.00
3.2
2.1
%
12.5
9.2
0.21
11
97
(3052592) Norovirus Ag [Presence] in Stool
7
78
0.90
0.00
1.1
1.4
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
57
0.88
0.00
1.4
1.2
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
440.4
—
0
7
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.5
—
3513.3
—
0
6
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
1.9
—
0
7
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
6
0.00
0.00
0.0
8.5
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
72
0.97
0.00
1.6
1.1
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MELANOMA_SKIN – Malignant melanoma of skin
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).